Physicians' Desk Reference Supplements 2004provides important updates between annual editions of PDR; sold as a set with Supplement A publishing in July and Supplement B publishing in September. |
Common terms and phrases
abnormal ADVAIR DISKUS adverse events ADVERSE REACTIONS ALIMTA amlodipine amprenavir approximately atorvastatin baseline blood bupropion Celexa CIPRO XR ciprofloxacin citalopram clearance CLINICAL PHARMACOLOGY clinical studies clinical trials Cmax concomitant CONTRAINDICATIONS controlled daptomycin decreased discontinued disease disorder DOSAGE AND ADMINISTRATION Drug Interactions effects elderly evaluated excreted exposure fluoxetine fluticasone propionate GlaxoSmithKline human hydrochloride hypotension immediate-release incidence increased inhalation inhibitors Injection intravenous KETEK LEVITRA LEXAPRO LEXIVA liver metabolism metabolites metformin mg/day mg/kg mg/kg/day mg/m² basis modafinil moxifloxacin nefazodone nevirapine observed occurred olanzapine once daily oral contraceptives oral dose pain paroxetine patients receiving patients treated PAXIL CR pediatric patients pharmacokinetics pills placebo placebo-controlled plasma concentrations potential pramipexole PRECAUTIONS pregnancy PROVIGIL RAPTIVA rats recommended renal reported risk RISPERDAL risperidone ritonavir rosuvastatin salmeterol SEROQUEL serum SERZONE STADOL SYMBYAX symptoms System Table Tablets tadalafil therapy tients tion treatment vardenafil VIRAMUNE vitro weeks zolmitriptan µg/mL